Abstract:Congenital myasthenia syndromes (CMS) are caused by genetic defects that impair neuromuscular transmission. Efficient synaptic transmission at the neuromuscular junction (NMJ) incorporates many different proteins involved both in the signal transmission itself and in generating the prerequisite specialized synaptic structures. As a consequence, there are multiple pathogenic mechanisms that can underlie CMS. A recent comprehensive review of CMS highlights many of these mechanisms [1▪▪] . There are currently 35 genes reported to be associated with CMS (Fig. 1 and Table 1). The prevalence reported varies considerably between regions, 2.8–14.8 per million (UK), 1.8 per million (Brazil), and 22.2 per million (Slovenia) [2] . Differences are likely to occur because of mutation founder effects in certain regions and historically because of different pick-up rates as new detection technologies are adopted. The clinical use of next-generation sequencing greatly facilitates detection of mutations in larger genes, such as AGRN , LRP4 , MUSK , COLQ , and thus increases in reported prevalence is likely to continue [3–7] . Whilst symptom onset at birth or infancy is the commonest presentation, later onset in childhood and adult life is now increasingly recognized. The clinical phenotypes can vary in the subtypes, but the hallmark is fatigable weakness predominantly affecting axial and proximal limb muscle, ocular, bulbar and or respiratory involvement. A suspected diagnosis is based on typical clinical features, decremental responses of 10% or more on repetitive nerve stimulation (RNS) and/or abnormal jitter and block on single-fibre EMG. It is prudent to note that RNS may show incremental response on high-frequency stimulation in some presynaptic (VAMP1, UNC13A, SYT2, RPH3A) and one synaptic (LAMA5) CMS subtype [8,9] . The inheritance patten in CMS is autosomal recessive except for dominant pattern seen in slow channel syndromes, SNAP25, PURA and some SYT2 patients [1▪▪] . Here, we highlight the widening phenotype spectrum associated with gene mutations that can not only have an effect of the NMJ but also show systemic and brain involvement (Table 2), and on current and emerging therapeutic strategies for CMS.

Mechanisms of Congenital Myasthenia Caused by Three Mutations in the COLQ Gene

Two Patients with Congenital Myasthenic Syndrome Caused by COLQ Gene Mutations and the Consequent ColQ Protein Defect.

Molecular Analysis of a Congenital Myasthenic Syndrome Due to a Pathogenic Variant Affecting the C-Terminus of ColQ

Novel chloride channel gene mutations in two unrelated Chinese families with myotonia congenita.

Clinical analysis and gene mutation screening of CLCN1 in two myotonia congenita families

A novel mutation leading to elongation of the deduced α1(X) chain results in Metaphyseal Chondrodysplasia type Schmid.

COLQ-Congenital myasthenic syndrome in an Iranian cohort: the clinical and genetics spectrum

Clinical and Pathologic Features of Congenital Myasthenic Syndromes Caused by 35 Genes-A Comprehensive Review

Congenital myasthenic syndromes: increasingly complex

Congenital myasthenia syndrome in a Chinese family with mutations in MUSK: A hotspot mutation and literature review.

Further observations in congenital myasthenic syndromes

Congenital Myasthenic Syndrome in China: Genetic and Myopathological Characterization

[Clinical and Genetic Characteristics of Congenital Myasthenia Syndrome with Episodic Apnea Caused by CHAT Gene Mutation: a Report of 2 Cases].

Limb-Girdle Congenital Myasthenic Syndrome in A Chinese Family with Novel Mutations in Musk Gene and Literature Review

Exome Sequencing Identified Two Novel COL10A1 Heterozygous Mutations in Two Irregular Dominance Chinese Pedigrees with Schmid-type Metaphyseal Chondrodysplasia

Identification of Two Novel COL10A1 Heterozygous Mutations in Two Chinese Pedigrees with Schmid-type Metaphyseal Chondrodysplasia

CHRNB1 Gene Mutations-Related Congenital Myasthenic Syndromes in a Chinese Family

A spontaneous missense mutation in the chromodomain helicase DNA-binding protein 8 (CHD8) gene: a novel association with congenital myasthenic syndrome

Limb Girdle Muscular Dystrophy 23 Caused by Compound Heterozygous Mutations of LAMA2 Gene

Spontaneous mutation in the COL6A2 gene causing Ullrich congenital muscular dystrophy type 1 in a Chinese child: A case report

Current understanding of congenital myasthenic syndromes